Results 151 to 160 of about 183,644 (348)

Angiotensin II Type 1 Receptor Antibody-Mediated Kidney Rejection Unresponsive to Treatment. [PDF]

Cureus, 2023
Allison D, Hajjiri Z, Manon L, Campbell-Lee S, Sahni S, Setty S.   +5 more
europepmc   +1 more source

Effect of angiotensin II type 1 receptor blockade on kidney ischemia/reperfusion; a gender-related difference [PDF]

, 2016
Fatemeh Moslemi, Pegah Taheri, Mahdis Azimipoor, Sina Ramtin, Mostafa Hashemianfar, Ali Momeni- Ashjerdi, Fatemeh Eshraghi-Jazi, Ardeshir Talebi, Hamid Nasri, Mehdi Nematbakhsh   +9 more
openalex   +1 more source

Perivascular Adipose Tissue Angiotensin II Type 1 Receptor Promotes Vascular Inflammation and Aneurysm Formation

HYPERTENSION, 2017
Tomoki Sakaue, J. Suzuki, Mika Hamaguchi, Chika Suehiro, A. Tanino, T. Nagao, T. Uetani, J. Aono, Hirotomo Nakaoka, M. Kurata, Tomohisa Sakaue, T. Okura, Takumi Yasugi, H. Izutani, J. Higaki, S. Ikeda   +15 more
semanticscholar   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Unraveling allostery within the angiotensin II type 1 receptor for Gα_q and β-arrestin coupling. [PDF]

Sci Signal, 2023
Cao Y, van der Velden WJC, Namkung Y, Nivedha AK, Cho A, Sedki D, Holleran B, Lee N, Leduc R, Muk S, Le K, Bhattacharya S, Vaidehi N, Laporte SA.   +13 more
europepmc   +1 more source

Implementation of guideline‐recommended medical therapy for patients with heart failure in Europe

ESC Heart Failure, Volume 12, Issue 2, Page 790-798, April 2025.
Abstract Physicians' adherence to guideline‐recommended heart failure (HF) treatment remains suboptimal, especially regarding the target doses. In particular, there is evidence that non‐cardiologists are less compliant with HF guideline recommendations. This is likely to have a detrimental impact on patients' survival, readmissions and quality of life.
Maurizio Volterrani, Petar Seferovic, Gianluigi Savarese, Ilaria Spoletini, Egidio Imbalzano, Antoni Bayes‐Genis, Ewa Jankowska, Michele Senni, Marco Metra, Ovidiu Chioncel, Andrew J. S. Coats, Giuseppe M. C. Rosano   +11 more
wiley   +1 more source

The Role of Angiotensin II Type 1 Receptor A1166C Polymorphism in Autosomal Dominant Polycystic Kidney Disease. [PDF]

Cureus, 2023
Sasidharan A, Mv B, Mani R, P S.
europepmc   +1 more source

Transactivation of the Insulin-Like Growth Factor-I Receptor by Angiotensin II Mediates Downstream Signaling from the Angiotensin II Type 1 Receptor to Phosphatidylinositol 3-Kinase [PDF]

, 2004
Peter Zahradka, Brenda Litchie, Ben Storie, Gail Helwer   +3 more
openalex   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Angiotensin II type 1 receptor antibodies and native kidney function in pediatric liver and intestinal transplant recipients. [PDF]

Pediatr Nephrol, 2023
Stern R, Chen L, Chan AP, Wozniak LJ, Pearl M.   +4 more
europepmc   +1 more source